Document ID: chunk:federal_register_of_legislation:F2021L00602:reg:9:p2
Version: federal_register_of_legislation:F2021L00602
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 7071–9770

reflux disease; and
(b)          commencing at least 5 years before the clinical worsening of gastro-oesophageal reflux disease; and
if smoking has ceased before the clinical worsening of gastro-oesophageal reflux disease, then that worsening occurred within 1 year of cessation;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(12)      consuming an average of at least 500 grams of alcohol per week for at least the 1 year before the clinical worsening of gastro-oesophageal reflux disease;
            Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(13)      undergoing surgery to the region of the oesophageal hiatus or surgery involving the fundus or body of the stomach, within the 6 months before the clinical worsening of gastro-oesophageal reflux disease;
            Note: Examples of surgery include oesophageal dilatation, bariatric surgery (such as laparoscopic adjustable gastric banding or laparoscopic sleeve gastrectomy) and per oral endoscopic myotomy (POEM).
(14)      taking a drug from the Specified List 1 of drugs at the time of the clinical worsening of gastro-oesophageal reflux disease;
Note: Specified List 1 of drugs is defined in the Schedule 1 - Dictionary.
(15)      having a disease from the specified list of diseases at the time of the clinical worsening of gastro-oesophageal reflux disease;
Note: specified list of diseases is defined in the Schedule 1 - Dictionary.
(16)      being pregnant at the time of the clinical worsening of gastro-oesophageal reflux disease;
(17)      having a disorder of mental health from the specified list of disorders of mental health at the time of the clinical worsening of gastro-oesophageal reflux disease;
Note: specified list of disorders of mental health is defined in the Schedule 1 - Dictionary.
(18)      taking orally a drug from the Specified List 2 of drugs at the time of the clinical worsening of gastro-oesophageal reflux disease;
Note: Specified List 2 of drugs is defined in the Schedule 1 - Dictionary.
(19)      taking orally a drug which is associated in the individual with the clinical worsening of gastro-oesophageal reflux disease during drug therapy and either:
(a)           the improvement of gastro-oesophageal reflux disease within 3 months of discontinuing or tapering drug therapy; or
(b)          the clinical worsening of gastro-oesophageal reflux disease on rechallenge with the same drug; and
where the drug was being taken at the time of the clinical worsening of gastro-oesophageal reflux disease;
(20)      inability to obtain appropriate clinical management for gastro-oesophageal reflux disease.